These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 27837020)

  • 1. Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.
    Spranger S; Luke JJ; Bao R; Zha Y; Hernandez KM; Li Y; Gajewski AP; Andrade J; Gajewski TF
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7759-E7768. PubMed ID: 27837020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma patients.
    González FE; Ramírez M; Allerbring EB; Fasching N; Lundqvist A; Poschke I; Achour A; Salazar-Onfray F
    Immunobiology; 2014 Mar; 219(3):189-97. PubMed ID: 24192537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing T-cell Infiltration in Tumors.
    Cancer Discov; 2017 Jan; 7(1):5-6. PubMed ID: 27927681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment.
    Gajewski TF; Corrales L; Williams J; Horton B; Sivan A; Spranger S
    Adv Exp Med Biol; 2017; 1036():19-31. PubMed ID: 29275462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
    Schrörs B; Lübcke S; Lennerz V; Fatho M; Bicker A; Wölfel C; Derigs P; Hankeln T; Schadendorf D; Paschen A; Wölfel T
    Oncotarget; 2017 Apr; 8(17):28312-28327. PubMed ID: 28423700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
    Sweis RF; Galsky MD
    Urol Oncol; 2016 Dec; 34(12):556-565. PubMed ID: 27836246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usage.
    Maeurer MJ; Hurd S; Martin DM; Storkus WJ; Lotze MT
    Cancer J Sci Am; 1995; 1(2):162-70. PubMed ID: 9166469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy.
    Robbins PF; el-Gamil M; Kawakami Y; Stevens E; Yannelli JR; Rosenberg SA
    Cancer Res; 1994 Jun; 54(12):3124-6. PubMed ID: 8205528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes.
    Viret C; Davodeau F; Guilloux Y; Bignon JD; Semana G; Breathnach R; Jotereau F
    Eur J Immunol; 1993 Jan; 23(1):141-6. PubMed ID: 8419164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of T Cell-Mediated Immune Surveillance on Somatic Mutation Occurrences in Melanoma.
    Jiang C; Schaafsma E; Hong W; Zhao Y; Zhu K; Chao CC; Cheng C
    Front Immunol; 2021; 12():703821. PubMed ID: 35111147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic recognition of malignant melanoma by autologous T lymphocytes.
    Carrel S; Johnson JP
    Curr Opin Oncol; 1993 Mar; 5(2):383-9. PubMed ID: 8457622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context.
    Godet Y; Moreau-Aubry A; Mompelat D; Vignard V; Khammari A; Dreno B; Lang F; Jotereau F; Labarriere N
    Cancer Immunol Immunother; 2010 Mar; 59(3):431-9. PubMed ID: 19730858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates.
    Griffioen M; Borghi M; Schrier PI; Osanto S; Schadendorf D
    Cancer Immunol Immunother; 2004 Aug; 53(8):715-22. PubMed ID: 14997347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery.
    de Sousa E; Lérias JR; Beltran A; Paraschoudi G; Condeço C; Kamiki J; António PA; Figueiredo N; Carvalho C; Castillo-Martin M; Wang Z; Ligeiro D; Rao M; Maeurer M
    Front Immunol; 2021; 12():592031. PubMed ID: 34335558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction.
    Hom SS; Topalian SL; Simonis T; Mancini M; Rosenberg SA
    J Immunother (1991); 1991 Jun; 10(3):153-64. PubMed ID: 1868040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor progression despite massive influx of activated CD8(+) T cells in a patient with malignant melanoma ascites.
    Harlin H; Kuna TV; Peterson AC; Meng Y; Gajewski TF
    Cancer Immunol Immunother; 2006 Oct; 55(10):1185-97. PubMed ID: 16468035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues.
    Parkhurst MR; Salgaller ML; Southwood S; Robbins PF; Sette A; Rosenberg SA; Kawakami Y
    J Immunol; 1996 Sep; 157(6):2539-48. PubMed ID: 8805655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.
    Valmori D; Fonteneau JF; Lizana CM; Gervois N; Liénard D; Rimoldi D; Jongeneel V; Jotereau F; Cerottini JC; Romero P
    J Immunol; 1998 Feb; 160(4):1750-8. PubMed ID: 9469433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.
    Li X; Xiang Y; Li F; Yin C; Li B; Ke X
    Front Immunol; 2019; 10():2293. PubMed ID: 31616443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases.
    Corbière V; Chapiro J; Stroobant V; Ma W; Lurquin C; Lethé B; van Baren N; Van den Eynde BJ; Boon T; Coulie PG
    Cancer Res; 2011 Feb; 71(4):1253-62. PubMed ID: 21216894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.